Donders Institute for Brain, Cognition, and Behavior and Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Radboud University Medical Center, Nijmegen, Netherlands.
Department of Medical Psychology & Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, Netherlands.
Lancet Neurol. 2019 Nov;18(11):998-1008. doi: 10.1016/S1474-4422(19)30285-6. Epub 2019 Sep 11.
High-intensity aerobic exercise might attenuate the symptoms of Parkinson's disease, but high-quality evidence is scarce. Moreover, long-term adherence remains challenging. We aimed to evaluate the effectiveness of aerobic exercise-gamified and delivered at home, to promote adherence-on relieving motor symptoms in patients with Parkinson's disease with mild disease severity who were on common treatment regimes.
In this single-centre, double-blind, randomised controlled trial (Park-in-Shape), we recruited sedentary patients with Parkinson's disease from the outpatient clinic at Radboudumc, Nijmegen, Netherlands. Patients were made aware of the study either by their treating neurologist or via information in the waiting room. Patients could also contact the study team via social media. We included patients aged 30-75 years with a Hoehn and Yahr stage of 2 or lower, who were on stable dopaminergic medication. Patients were randomly assigned (in a 1:1 ratio) to either aerobic exercise done on a stationary home-trainer (aerobic intervention group) or stretching (active control group) by means of a web-based system with minimisation for sex and medication status (treated or untreated) and permuted blocks of varying sizes of more than two (unknown to study personnel). Patients were only aware of the content of their assigned programme. Assessors were unaware of group assignments. Both interventions were home based, requiring 30-45 min training three times per week for 6 months. Both groups received a motivational app and remote supervision. Home trainers were enhanced with virtual reality software and real-life videos providing a so-called exergaming experience (ie, exercise enhanced by gamified elements). The primary outcome was the between-group difference in the Movement Disorders Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) motor section at 6 months, tested during the off state (≥12 h after last dopaminergic medication). The analysis was done on an intention-to-treat basis in patients who completed the follow-up assessment, regardless of whether they completed the assigned intervention. Patients reported adverse events directly to their coach and also after the 6-month visit retrospectively. A between-group difference of 3·5 points or more was deemed a-priori clinically relevant. The study is concluded and registered with the Dutch Trial Registry, NTR4743.
Between Feb 2, 2015, and Oct 27, 2017, 139 patients were assessed for eligibility in person, of whom 130 were randomly assigned to either the aerobic intervention group (n=65) or the active control group (n=65). Data from 125 (96%) patients were available for the primary analysis; five patients were lost to follow-up (four in the intervention group; one in the control group). 20 patients (ten in each group) did not complete their assigned programme. The off-state MDS-UPDRS motor score revealed a between-group difference of 4·2 points (95% CI 1·6-6·9, p=0·0020) in favour of aerobic exercise (mean 1·3 points [SE 1·8] in the intervention group and 5·6 points [SE 1·9] for the control group). 11 patients had potentially related adverse events (seven [11%] in the intervention group, four [6%] in the control group) and seven had unrelated serious adverse events (three in the intervention group [vestibilar disorder, vasovagal collapse, knee injury during gardening that required surgery; 6%], four in the control group [supraventricular tachycardia, hip fracture, fall related injury, severe dyskinesias after suprathreshold dose levodopa in a patient with deep brain stimulation; 7%]).
Aerobic exercise can be done at home by patients with Parkinson's disease with mild disease severity and it attenuates off-state motor signs. Future studies should establish long-term effectiveness and possible disease-modifying effects.
Netherlands Organization for Health Research and Development.
高强度有氧运动可能会减轻帕金森病的症状,但高质量证据稀缺。此外,长期坚持也具有挑战性。我们旨在评估在家中进行的有氧游戏化运动对轻度疾病严重程度的帕金森病患者的疗效,这些患者正在接受常见的治疗方案。
在这项单中心、双盲、随机对照试验(Park-in-Shape)中,我们从荷兰奈梅亨拉德堡德大学医学中心的门诊招募了久坐的帕金森病患者。通过他们的治疗神经科医生或候诊室中的信息,让患者了解这项研究。患者也可以通过社交媒体联系研究团队。我们纳入了年龄在 30-75 岁之间、Hoehn 和 Yahr 分期为 2 级或更低、正在服用稳定多巴胺能药物的患者。患者以 1:1 的比例随机分配到固定家用健身车(有氧运动干预组)或拉伸(主动对照组),通过基于网络的系统进行分配,最小化性别和药物状态(治疗或未治疗)的影响,并使用大小超过两个的随机化分组(研究人员不知道)。患者只知道他们分配到的方案内容。评估人员不知道分组情况。两种干预措施都是家庭为基础的,需要每周三次、每次 30-45 分钟,持续 6 个月。两组都收到了一个激励应用程序和远程监督。家用健身车通过虚拟现实软件和提供所谓的有氧运动体验(即通过游戏化元素增强的运动)的真实生活视频进行增强。主要结局是在 6 个月时处于停药状态(最后一次多巴胺能药物治疗后 12 小时以上)的运动障碍协会统一帕金森病评定量表(MDS-UPDRS)运动部分的组间差异,该评估在完成随访评估的患者中进行,无论他们是否完成了分配的干预。患者直接向他们的教练报告不良事件,并在 6 个月就诊后回顾性报告。预先设定的 3.5 分或以上的组间差异被认为具有临床意义。该研究已经结束,并在荷兰试验注册处(NTR4743)进行了注册。
2015 年 2 月 2 日至 2017 年 10 月 27 日,有 139 名患者接受了现场资格评估,其中 130 名患者被随机分配到有氧运动干预组(n=65)或主动对照组(n=65)。125 名(96%)患者的数据可用于主要分析;5 名患者失访(干预组 4 名,对照组 1 名)。20 名患者(每组各 10 名)未完成他们分配的方案。停药状态下的 MDS-UPDRS 运动评分显示,有氧运动组的运动评分比对照组低 4.2 分(95%CI 1.6-6.9,p=0.0020),优势明显(干预组平均 1.3 分[SE 1.8],对照组平均 5.6 分[SE 1.9])。11 名患者出现潜在相关不良事件(干预组 7 名[11%],对照组 4 名[6%]),7 名患者出现无关严重不良事件(干预组 3 名[前庭障碍、血管迷走性晕厥、在接受深部脑刺激的患者中因服用阈上剂量左旋多巴引起的膝伤;6%],对照组 4 名[室上性心动过速、髋部骨折、跌倒相关损伤、深部脑刺激患者服用阈上剂量左旋多巴后严重运动障碍;7%])。
患有轻度疾病严重程度的帕金森病患者可以在家中进行有氧运动,并且可以减轻停药状态下的运动症状。未来的研究应该确定长期疗效和可能的疾病修饰作用。
荷兰健康研究与发展组织。